Figure 1.

Comparison of treatment sequences and termination locations for patients in the vancomycin intravenous (IV) and linezolid (Lzd) groups. *Therapies included amoxicillin-clavulanic acid, doxycycline, ciprofloxacin, ciprofloxacin plus clindamycin, clindamycin, metronidazole, trimethoprimsulfamethoxazole; ^†Cefazolin; ^‡Ciprofloxacin, metronidazole; ^§Imipenem; ^¶One patient was discharged on vancomycin IV, but switched to oral therapy postdischarge. MRSA Methicillin-resistant Staphylococcus aureus